Cyclic compounds and methods of using same

The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MONDAL Sayan, TANG Haifeng, FRYE Leah, KONST Zef, LEVINSON Adam Marc, GREENWOOD Jeremy Robert, GHANAKOTA Phani, BOS Pieter Harm, HUANG Xianhai, BHAT Sathesh
Format: Patent
Sprache:eng ; heb
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MONDAL Sayan
TANG Haifeng
FRYE Leah
KONST Zef
LEVINSON Adam Marc
GREENWOOD Jeremy Robert
GHANAKOTA Phani
BOS Pieter Harm
HUANG Xianhai
BHAT Sathesh
description The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for inhibiting kinase activity, and for treating cancer.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IL305925A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IL305925A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IL305925A3</originalsourceid><addsrcrecordid>eNrjZNByrkzOyUxWSM7PLcgvzUspVkjMS1HITS3JyAey89MUSosz89IVihNzU3kYWNMSc4pTeaE0N4Ocm2uIs4duakF-fGpxQWJyal5qSbynj7GBqaWRqaMxQQUAMFcnmg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Cyclic compounds and methods of using same</title><source>esp@cenet</source><creator>MONDAL Sayan ; TANG Haifeng ; FRYE Leah ; KONST Zef ; LEVINSON Adam Marc ; GREENWOOD Jeremy Robert ; GHANAKOTA Phani ; BOS Pieter Harm ; HUANG Xianhai ; BHAT Sathesh</creator><creatorcontrib>MONDAL Sayan ; TANG Haifeng ; FRYE Leah ; KONST Zef ; LEVINSON Adam Marc ; GREENWOOD Jeremy Robert ; GHANAKOTA Phani ; BOS Pieter Harm ; HUANG Xianhai ; BHAT Sathesh</creatorcontrib><description>The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for inhibiting kinase activity, and for treating cancer.</description><language>eng ; heb</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231101&amp;DB=EPODOC&amp;CC=IL&amp;NR=305925A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231101&amp;DB=EPODOC&amp;CC=IL&amp;NR=305925A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MONDAL Sayan</creatorcontrib><creatorcontrib>TANG Haifeng</creatorcontrib><creatorcontrib>FRYE Leah</creatorcontrib><creatorcontrib>KONST Zef</creatorcontrib><creatorcontrib>LEVINSON Adam Marc</creatorcontrib><creatorcontrib>GREENWOOD Jeremy Robert</creatorcontrib><creatorcontrib>GHANAKOTA Phani</creatorcontrib><creatorcontrib>BOS Pieter Harm</creatorcontrib><creatorcontrib>HUANG Xianhai</creatorcontrib><creatorcontrib>BHAT Sathesh</creatorcontrib><title>Cyclic compounds and methods of using same</title><description>The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for inhibiting kinase activity, and for treating cancer.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNByrkzOyUxWSM7PLcgvzUspVkjMS1HITS3JyAey89MUSosz89IVihNzU3kYWNMSc4pTeaE0N4Ocm2uIs4duakF-fGpxQWJyal5qSbynj7GBqaWRqaMxQQUAMFcnmg</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>MONDAL Sayan</creator><creator>TANG Haifeng</creator><creator>FRYE Leah</creator><creator>KONST Zef</creator><creator>LEVINSON Adam Marc</creator><creator>GREENWOOD Jeremy Robert</creator><creator>GHANAKOTA Phani</creator><creator>BOS Pieter Harm</creator><creator>HUANG Xianhai</creator><creator>BHAT Sathesh</creator><scope>EVB</scope></search><sort><creationdate>20231101</creationdate><title>Cyclic compounds and methods of using same</title><author>MONDAL Sayan ; TANG Haifeng ; FRYE Leah ; KONST Zef ; LEVINSON Adam Marc ; GREENWOOD Jeremy Robert ; GHANAKOTA Phani ; BOS Pieter Harm ; HUANG Xianhai ; BHAT Sathesh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IL305925A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; heb</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MONDAL Sayan</creatorcontrib><creatorcontrib>TANG Haifeng</creatorcontrib><creatorcontrib>FRYE Leah</creatorcontrib><creatorcontrib>KONST Zef</creatorcontrib><creatorcontrib>LEVINSON Adam Marc</creatorcontrib><creatorcontrib>GREENWOOD Jeremy Robert</creatorcontrib><creatorcontrib>GHANAKOTA Phani</creatorcontrib><creatorcontrib>BOS Pieter Harm</creatorcontrib><creatorcontrib>HUANG Xianhai</creatorcontrib><creatorcontrib>BHAT Sathesh</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MONDAL Sayan</au><au>TANG Haifeng</au><au>FRYE Leah</au><au>KONST Zef</au><au>LEVINSON Adam Marc</au><au>GREENWOOD Jeremy Robert</au><au>GHANAKOTA Phani</au><au>BOS Pieter Harm</au><au>HUANG Xianhai</au><au>BHAT Sathesh</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Cyclic compounds and methods of using same</title><date>2023-11-01</date><risdate>2023</risdate><abstract>The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for inhibiting kinase activity, and for treating cancer.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; heb
recordid cdi_epo_espacenet_IL305925A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Cyclic compounds and methods of using same
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T19%3A20%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MONDAL%20Sayan&rft.date=2023-11-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIL305925A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true